Literature DB >> 22236878

The heat shock proteins as targets for radiosensitization and chemosensitization in cancer.

David M Guttmann1, Constantinos Koumenis.   

Abstract

The heat shock proteins (HSPs) represent a class of proteins which are induced under physiologic stress to promote cell survival in the face of endogenous or exogenous injury. HSPs function predominantly as molecular chaperones, maintaining their "client" proteins in the correct conformational state in order to withstand a biologic stressor. Elevated HSP expression is also found in a range of pathologic conditions, notably malignancy. Cancer cells exploit the pro-survival phenotype endowed by HSPs to bolster their proliferative potential. Consequently, developing means of abrogating HSP expression may provide a way to render cancer cells more susceptible to radiation or chemotherapy. Here, we review the members of the HSP class and their roles in malignancy. We focus on attempts to target these proteins, particularly the small HSPs, in developing potent radiation and chemotherapy sensitizers, as well as proposed mechanisms for this sensitization effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22236878      PMCID: PMC3335937          DOI: 10.4161/cbt.12.12.18374

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  94 in total

1.  Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death.

Authors:  P Mehlen; C Kretz-Remy; X Préville; A P Arrigo
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs.

Authors:  C Garrido; P Ottavi; A Fromentin; A Hammann; A P Arrigo; B Chauffert; P Mehlen
Journal:  Cancer Res       Date:  1997-07-01       Impact factor: 12.701

Review 3.  Heat shock, stress proteins, chaperones, and proteotoxicity.

Authors:  L E Hightower
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

4.  Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association.

Authors:  T W Schulte; M V Blagosklonny; C Ingui; L Neckers
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

Review 5.  The heat-shock proteins.

Authors:  S Lindquist; E A Craig
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

6.  Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases.

Authors:  M Jäättelä; D Wissing; K Kokholm; T Kallunki; M Egeblad
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

7.  Intracellular reactive oxygen species as apparent modulators of heat-shock protein 27 (hsp27) structural organization and phosphorylation in basal and tumour necrosis factor alpha-treated T47D human carcinoma cells.

Authors:  P Mehlen; C Kretz-Remy; J Briolay; P Fostan; M E Mirault; A P Arrigo
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

8.  Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.

Authors:  Palma Rocchi; Alan So; Satoko Kojima; Maxim Signaevsky; Eliana Beraldi; Ladan Fazli; Antonio Hurtado-Coll; Kazuki Yamanaka; Martin Gleave
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

9.  Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy.

Authors:  L M Vargas-Roig; F E Gago; O Tello; J C Aznar; D R Ciocca
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

10.  Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27.

Authors:  J N Lavoie; H Lambert; E Hickey; L A Weber; J Landry
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

View more
  9 in total

1.  Suppression of heat shock protein 70 by siRNA enhances the antitumor effects of cisplatin in cultured human osteosarcoma cells.

Authors:  Yuki Mori; Ryu Terauchi; Toshiharu Shirai; Shinji Tsuchida; Naoki Mizoshiri; Yuji Arai; Tsunao Kishida; Hiroyoshi Fujiwara; Osam Mazda; Toshikazu Kubo
Journal:  Cell Stress Chaperones       Date:  2017-05-02       Impact factor: 3.667

2.  Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy.

Authors:  Gustavo J Gozzi; Daniel Gonzalez; Christophe Boudesco; Alexandre M M Dias; Guillaume Gotthard; Burhan Uyanik; Lucile Dondaine; Guillaume Marcion; François Hermetet; Camille Denis; Laurianne Hardy; Peggy Suzanne; Romain Douhard; Gaetan Jego; Laurence Dubrez; Oleg N Demidov; Fabrice Neiers; Loïc Briand; Jana Sopková-de Oliveira Santos; Anne-Sophie Voisin-Chiret; Carmen Garrido
Journal:  Cell Death Differ       Date:  2019-05-08       Impact factor: 15.828

3.  A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer.

Authors:  Anna V Gaponova; Anna S Nikonova; Alexander Deneka; Meghan C Kopp; Alexander E Kudinov; Natalia Skobeleva; Vladimir Khazak; Luisa S Ogawa; Kathy Q Cai; Kelly E Duncan; James S Duncan; Brian L Egleston; David A Proia; Yanis Boumber; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2016-06-07       Impact factor: 12.531

4.  Radiation, inflammation, and immune responses in cancer.

Authors:  Gabriele Multhoff; Jürgen Radons
Journal:  Front Oncol       Date:  2012-06-04       Impact factor: 6.244

5.  Differentially expressed proteins in nitric oxide-stimulated NIH/3T3 fibroblasts: implications for inhibiting cancer development.

Authors:  Dong Hwi Shim; Joo Weon Lim; Hyeyoung Kim
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

6.  Induction of Hsp70 in tumor cells treated with inhibitors of the Hsp90 activity: A predictive marker and promising target for radiosensitization.

Authors:  Vladimir A Kudryavtsev; Anna V Khokhlova; Vera A Mosina; Elena I Selivanova; Alexander E Kabakov
Journal:  PLoS One       Date:  2017-03-14       Impact factor: 3.240

7.  Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922.

Authors:  Annett Kühnel; Daniela Schilling; Stephanie E Combs; Bernhard Haller; Melissa Schwab; Gabriele Multhoff
Journal:  Cells       Date:  2019-09-28       Impact factor: 6.600

8.  WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma.

Authors:  Céline S Gonçalves; Joana Vieira de Castro; Marta Pojo; Eduarda P Martins; Sandro Queirós; Emmanuel Chautard; Ricardo Taipa; Manuel Melo Pires; Afonso A Pinto; Fernando Pardal; Carlos Custódia; Cláudia C Faria; Carlos Clara; Rui M Reis; Nuno Sousa; Bruno M Costa
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

Review 9.  Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy.

Authors:  Gaëtan Jego; François Hermetet; François Girodon; Carmen Garrido
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.